Related references
Note: Only part of the references are listed.Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise A randomized, double-blind, placebo-controlled, phase 3 trial
Ele Ferrannini et al.
DIABETES CARE (2010)
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2
William N. Washburn
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
How drugs interact with transporters: SGLT1 as a model
Donald D. F. Loo et al.
JOURNAL OF MEMBRANE BIOLOGY (2008)
The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport
Salem Faham et al.
SCIENCE (2008)
Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters
Ana M. Pajor et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Kenji Katsuno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Long-term outcome of renal glucosuria type 0:: the original patient and his natural history
S Scholl-Bürgi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Molecular analysis of the SGLT2 gene in patients with renal glucosuria
R Santer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Common mechanisms of inhibition for the Na+/glucose (hSGLT1) and Na+/Cl-/GABA (hGAT1) cotransporters
BA Hirayama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Renal Na+-glucose cotransporters
EM Wright
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
Share Paper
